202 related articles for article (PubMed ID: 9915339)
1. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.
Ramsay MA; Spikes C; East CA; Lynch K; Hein HA; Ramsay KJ; Klintmalm GB
Anesthesiology; 1999 Jan; 90(1):299-301. PubMed ID: 9915339
[No Abstract] [Full Text] [Related]
2. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension.
Plotkin JS; Kuo PC; Rubin LJ; Gaine S; Howell CD; Laurin J; Njoku MJ; Lim JW; Johnson LB
Transplantation; 1998 Feb; 65(4):457-9. PubMed ID: 9500616
[TBL] [Abstract][Full Text] [Related]
3. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation.
Kett DH; Acosta RC; Campos MA; Rodriguez MJ; Quartin AA; Schein RM
Liver Transpl; 2001 Jul; 7(7):645-8. PubMed ID: 11460234
[TBL] [Abstract][Full Text] [Related]
4. Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension.
Schroeder RA; Rafii AA; Plotkin JS; Johnson LB; Rustgi VK; Kuo PC
Transplantation; 2000 Aug; 70(3):548-50. PubMed ID: 10949204
[TBL] [Abstract][Full Text] [Related]
5. Moderate-term effect of epoprostenol on severe portopulmonary hypertension.
Kato H; Katori T; Nakamura Y; Kawarasaki H
Pediatr Cardiol; 2003; 24(1):50-3. PubMed ID: 12574979
[TBL] [Abstract][Full Text] [Related]
6. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension.
Kuo PC; Johnson LB; Plotkin JS; Howell CD; Bartlett ST; Rubin LJ
Transplantation; 1997 Feb; 63(4):604-6. PubMed ID: 9047158
[TBL] [Abstract][Full Text] [Related]
7. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
[TBL] [Abstract][Full Text] [Related]
8. Epoprostenol and nitric oxide therapy for severe pulmonary hypertension in liver transplantation.
Molmenti EP; Ramsay M; Ramsay K; Lynch K; Tillmann Hein HA; Molmenti H; Levy M; Goldstein R; Ausloos K; East C; Fasola C; Jung G; Escobar J; Klintmalm G
Transplant Proc; 2001; 33(1-2):1332. PubMed ID: 11267313
[No Abstract] [Full Text] [Related]
9. Successful liver transplantation in a child with severe portopulmonary hypertension treated with epoprostenol.
Laving A; Khanna A; Rubin L; Ing F; Dohil R; Lavine JE
J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):466-8. PubMed ID: 16205516
[No Abstract] [Full Text] [Related]
10. Intraoperative epoprostenol and nitric oxide for severe pulmonary hypertension during orthotopic liver transplantation: a case report and review of the literature.
Vater Y; Martay K; Dembo G; Bowdle TA; Weinbroum AA
Med Sci Monit; 2006 Dec; 12(12):CS115-118. PubMed ID: 17136012
[TBL] [Abstract][Full Text] [Related]
11. Portopulmonary hypertension: imatinib as a novel treatment and the Emory experience with this condition.
Tapper EB; Knowles D; Heffron T; Lawrence EC; Csete M
Transplant Proc; 2009 Jun; 41(5):1969-71. PubMed ID: 19545770
[TBL] [Abstract][Full Text] [Related]
12. Intravenous prostacyclin combined with inhaled nitric oxide therapy for an infant with alveolar capillary dysplasia.
Kinugasa H; Horigome H; Sugiura M; Saito T; Iijima T; Matsui A
Pediatr Int; 2002 Oct; 44(5):525-7. PubMed ID: 12225554
[No Abstract] [Full Text] [Related]
13. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
14. [Epoprostenol in the treatment of portopulmonary hypertension].
Culafić D; Culafić-Vojinović V; Jesić R
Srp Arh Celok Lek; 2003; 131(5-6):271-4. PubMed ID: 14692137
[TBL] [Abstract][Full Text] [Related]
15. Prostacyclin in portopulmonary hypertension.
Sinzinger H
Wien Klin Wochenschr; 2000 Dec; 112(23):1020-1. PubMed ID: 11190712
[No Abstract] [Full Text] [Related]
16. Treatment of pulmonary arterial hypertension.
Humbert M; Sitbon O; Simonneau G
N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
[No Abstract] [Full Text] [Related]
17. Successful management of portopulmonary hypertension with beraprost.
Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
[TBL] [Abstract][Full Text] [Related]
18. [Perioperative management of living-donor liver transplantation in two patients with severe portopulmonary hypertension].
Tominaga M; Furutani H; Segawa H; Shoda T; Mima H; Adachi T; Fukuda K
Masui; 2003 Jul; 52(7):729-32. PubMed ID: 12910972
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension.
Mikhail G; Gibbs J; Richardson M; Wright G; Khaghani A; Banner N; Yacoub M
Eur Heart J; 1997 Sep; 18(9):1499-504. PubMed ID: 9458458
[TBL] [Abstract][Full Text] [Related]
20. Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol.
Rafanan AL; Maurer J; Mehta AC; Schilz R
Chest; 2000 Nov; 118(5):1497-500. PubMed ID: 11083710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]